Fredun Pharmaceuticals Ltd — Board Meeting, 31-05-2025: Board Meeting

Fredun Pharmaceuticals has announced a board meeting on May 30, 2025, where it approved the financial results for the quarter and half-year ended March 31, 2025. The company reported consolidated revenue of Rs. 451.71 Cr, up from Rs. 346.58 Cr the previous year, and net profit rose to Rs. 20.81 Cr from Rs. 15.62 Cr. Earnings per share improved to Rs. 44.83 from Rs. 33.66. A final dividend of 7% on equity shares is proposed, subject to shareholder approval. The statutory auditors issued an unmodified opinion, confirming the accuracy of the financials. Notably, there’s a delay in transferring unclaimed dividends and shares to the Investor Education and Protection Fund for FY 2015-16 and FY 2016-17. The group expanded by incorporating Fredun Retail Private Limited and acquiring One Pet Stop Private Limited, both included in the consolidated results for the first time.